Wake Forest University Health Sciences
To evaluate the real-world effectiveness and implementation strategies for mPATH-Lung, investigators propose a pragmatic, randomized controlled trial across an academic Learning Health System. The trial will contrast several approaches to participant outreach and will specifically target engaging fully powered cohorts of racial/ethnic minorities and rural residents.
Lung Cancer
Portal Message with Reminder Text Messages
Text Message with Reminder Text Messages
Portal message only
Usual Care
NA
Primary Objective: Evaluate the real-world effectiveness of mPATH-Lung in increasing lung cancer screening rates across diverse populations. Secondary Objectives * Compare the differential effectiveness of three outreach strategies for engaging participants with mPATH-Lung across vulnerable rural or ethnic/racial minority population subgroups. * Estimate the additional revenue generated by mPATH-Lung through increased screening and downstream care. * Evaluate the potential for over-screening and the impact of applying HEDIS-based exclusion criteria
| Study Type : | INTERVENTIONAL |
| Estimated Enrollment : | 27000 participants |
| Masking : | SINGLE |
| Primary Purpose : | SCREENING |
| Official Title : | A Pragmatic Randomized-Controlled Learning Health System Trial |
| Actual Study Start Date : | 2026-03-25 |
| Estimated Primary Completion Date : | 2027-01 |
| Estimated Study Completion Date : | 2027-01 |
Information not available for Arms and Intervention/treatment
| Ages Eligible for Study: | 50 Years to 77 Years |
| Sexes Eligible for Study: | ALL |
| Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
RECRUITING
Atrium Health Wake Forest Baptist
Winston-Salem, North Carolina, United States, 27157